{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T02:44:14Z","timestamp":1746413054189},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,22]]},"DOI":"10.7759\/cureus.18974","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T14:22:16Z","timestamp":1634912536000},"source":"Crossref","is-referenced-by-count":3,"title":["Fulminant Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis After 10 Years of Hydralazine Use"],"prefix":"10.7759","author":[{"given":"Jose  R","family":"Russe-Russe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R","family":"Pellegrini Jr.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Alvarez-Betancourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rezwan F","family":"Munshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prachi","family":"Anand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7245.1325","article-title":"ABC of arterial and vascular disease: vasculitis","volume":"320","author":"Savage CO","year":"2000","unstructured":"Savage CO, Harper L, Cockwell P, Adu D, Howie AJ. ABC of arterial and vascular disease: vasculitis. BMJ. 2000, 320:1325-8. 10.1136\/bmj.320.7245.1325","journal-title":"BMJ"},{"key":"ref2","article-title":"Drug-induced vasculitis: a clinical and pathological review","volume":"70","author":"Radi\u0107 M","year":"2012","unstructured":"Radi\u0107 M, Martinovi\u0107 Kaliterna D, Radi\u0107 J. Drug-induced vasculitis: a clinical and pathological review. Neth J Med. 2012, 70:12-7.","journal-title":"Neth J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/01.asn.0000016442.33680.3e","article-title":"ANCA-positive vasculitis","volume":"13","author":"Kamesh L","year":"2002","unstructured":"Kamesh L, Harper L, Savage CO. ANCA-positive vasculitis. J Am Soc Nephrol. 2002, 13:1953-60. 10.1097\/01.asn.0000016442.33680.3e","journal-title":"J Am Soc Nephrol"},{"key":"ref4","unstructured":"Clinical spectrum of antineutrophil cytoplasmic autoantibodies. (2018). Accessed. August 10, 2021: https:\/\/www.uptodate.com\/contents\/clinical-spectrum-of-antineutrophil-cytoplasmic-autoantibodies#H2654479157."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704302","article-title":"Mechanisms of hydralazine induced vasodilation in rabbit aorta and pulmonary artery","volume":"134","author":"Ellershaw DC","year":"2001","unstructured":"Ellershaw DC, Gurney AM. Mechanisms of hydralazine induced vasodilation in rabbit aorta and pulmonary artery. Br J Pharmacol. 2001, 134:621-31. 10.1038\/sj.bjp.0704302","journal-title":"Br J Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure","volume":"351","author":"Taylor AL","year":"2004","unstructured":"Taylor AL, Ziesche S, Yancy C, et al.. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med. 2004, 351:2049-57. 10.1056\/NEJMoa042934","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.118.310957","article-title":"Advances in therapies and imaging for systemic vasculitis","volume":"39","author":"Farrah TE","year":"2019","unstructured":"Farrah TE, Basu N, Dweck M, Calcagno C, Fayad ZA, Dhaun N. Advances in therapies and imaging for systemic vasculitis. Arterioscler Thromb Vasc Biol. 2019, 39:1520-41. 10.1161\/ATVBAHA.118.310957","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.03.029","article-title":"Anti-neutrophil cytoplasmic antibody associated glomerulonephritis complicating treatment with hydralazine","volume":"100","author":"Santoriello D","year":"2021","unstructured":"Santoriello D, Bomback AS, Kudose S, et al.. Anti-neutrophil cytoplasmic antibody associated glomerulonephritis complicating treatment with hydralazine. Kidney Int. 2021, 100:440-6. 10.1016\/j.kint.2021.03.029","journal-title":"Kidney Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000014","article-title":"Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis","volume":"26","author":"Pendergraft WF 3rd","year":"2014","unstructured":"Pendergraft WF 3rd, Niles JL. Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis. Curr Opin Rheumatol. 2014, 26:42-9. 10.1097\/BOR.0000000000000014","journal-title":"Curr Opin Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2018.01.005","article-title":"Hydralazine-associated vasculitis: overlapping features of drug-induced lupus and vasculitis","volume":"48","author":"Kumar B","year":"2018","unstructured":"Kumar B, Strouse J, Swee M, Lenert P, Suneja M. Hydralazine-associated vasculitis: overlapping features of drug-induced lupus and vasculitis. Semin Arthritis Rheum. 2018, 48:283-7. 10.1016\/j.semarthrit.2018.01.005","journal-title":"Semin Arthritis Rheum"},{"key":"ref11","article-title":"Antigen specificity in hydralazine associated ANCA positive systemic vasculitis","volume":"88","author":"Short AK","year":"1995","unstructured":"Short AK, Lockwood CM. Antigen specificity in hydralazine associated ANCA positive systemic vasculitis. QJM. 1995, 88:775-83.","journal-title":"QJM"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-011-9989-7","article-title":"Hydralazine-induced ANCA vasculitis with pulmonary renal syndrome: a rare clinical presentation","volume":"44","author":"Marina VP","year":"2012","unstructured":"Marina VP, Malhotra D, Kaw D. Hydralazine-induced ANCA vasculitis with pulmonary renal syndrome: a rare clinical presentation. Int Urol Nephrol. 2012, 44:1907-9. 10.1007\/s11255-011-9989-7","journal-title":"Int Urol Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200002)43:2<405::AID-ANR22>3.0.CO;2-5","article-title":"Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies","volume":"43","author":"Choi HK","year":"2000","unstructured":"Choi HK, Merkel PA, Walker AM, Niles JL. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum. 2000, 43:405-13. 10.1002\/1529-0131(200002)43:2&lt;405::AID-ANR22&gt;3.0.CO;2-5","journal-title":"Arthritis Rheum"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-009-0168-y","article-title":"Hydralazine-induced autoimmune disease: comparison to idiopathic lupus and ANCA-positive vasculitis","volume":"19","author":"Yokogawa N","year":"2009","unstructured":"Yokogawa N, Vivino FB. Hydralazine-induced autoimmune disease: comparison to idiopathic lupus and ANCA-positive vasculitis. Mod Rheumatol. 2009, 19:338-47. 10.1007\/s10165-009-0168-y","journal-title":"Mod Rheumatol"},{"key":"ref15","unstructured":"Very Well Health. What is a C-reactive protein (CRP) test? The test that can detect inflammation. (2021). Accessed: October 15, 2020: https:\/\/www.verywellhealth.com\/what-is-the-c-reactive-protein-crp-test-188021."},{"key":"ref16","unstructured":"Find Lab Test. (2021). Accessed. October 15, 2020: https:\/\/www.findlabtest.com\/lab-test\/autoimmune-diseases\/anca-vasculitides-quest-36733."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv002","article-title":"Disease assessment in systemic vasculitis","volume":"30","author":"Luqmani RA","year":"2015","unstructured":"Luqmani RA. Disease assessment in systemic vasculitis. Nephrol Dial Transplant. 2015, 30:i76-82. 10.1093\/ndt\/gfv002","journal-title":"Nephrol Dial Transplant"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151063","article-title":"The Birmingham Vasculitis Activity Score as a measure of disease activity in patients with giant cell arteritis","volume":"43","author":"Kermani TA","year":"2016","unstructured":"Kermani TA, Cuthbertson D, Carette S, et al.. The Birmingham Vasculitis Activity Score as a measure of disease activity in patients with giant cell arteritis. J Rheumatol. 2016, 43:1078-84. 10.3899\/jrheum.151063","journal-title":"J Rheumatol"},{"key":"ref19","unstructured":"Canadian Network for Research on Vasculitides. (2021). Accessed. October 18, 2020: https:\/\/www.canvasc.ca\/tools.htm."},{"key":"ref20","article-title":"Clinical Evaluation of Systemic Vasculitis: A Practical Guide to Using BVAS and VDI (Version 8.1)","author":"Luqmani RA","year":"2018","unstructured":"Luqmani RA, Brown D, Hall C, et al.. Clinical Evaluation of Systemic Vasculitis: A Practical Guide to Using BVAS and VDI (Version 8.1). University of Oxford, Edinburgh; 2018."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/72091-fulminant-anti-neutrophil-cytoplasmic-antibody-associated-vasculitis-after-10-years-of-hydralazine-use","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:32:01Z","timestamp":1707507121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/72091-fulminant-anti-neutrophil-cytoplasmic-antibody-associated-vasculitis-after-10-years-of-hydralazine-use"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,22]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.18974","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,22]]}}}